Dusan Perovic
Partner at Two Sigma Ventures
New York, New York
Overview
Work Experience
Board Observer
2024 - Current
Partner
2016
Two Sigma Ventures is an early-stage venture capital fund that invests in companies run by highly driven people.
Board Member
2024
Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.
Raised $73,000,000.00 from Yes VC, Jack Abraham, Two Sigma Ventures, SALT Fund, Myelin VC, Plum Alley, Chelsea M.R. Hirschhorn, FJ Labs, Insight Partners and TA Ventures.
Investor
2024
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.
Raised $1,000,000,000.00 from Lux Capital, SV Angel, Two Sigma Ventures, F-Prime Capital, R-Squared Ventures, Foresite Capital, Byers Capital, ARCH Venture Partners, Lightspeed Venture Partners and New Enterprise Associates.
Board Member
2019
Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.
Raised $200,000,000.00 from What If Ventures, Digitalis Ventures, NVentures, Goldcrest Capital, XTX Ventures, Alexandria Venture Investments, Madrona, Maverick Capital, Two Sigma Ventures and Bedford Ridge Capital.
Investor
2018
Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.
Raised $643,000,000.00 from Alexandria Venture Investments, BlackRock, HOF Capital, CPP Investments, Google Ventures, Foresite Capital, Casdin Capital, Temasek Holdings, T. Rowe Price and Third Rock Ventures.
Board Observer
2020
Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.
Raised $193,600,001.00 from Two Sigma Ventures, The Column Group, Nextech Invest, 8VC, CPP Investments and ATEL Growth Capital.
Board Member
2022
Freeform is a 3D printing company offering metal 3D printing solutions for manufacturing companies.
Raised $59,000,000.00 from NVentures, AE Industrial Partners, Two Sigma Ventures, Threshold, Founders Fund and 10x Founders.
Board Member
2020
Board Observer
2021
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.
Raised $67,500,000.00 from Section 32, Casdin Capital and Two Sigma Ventures.